Bezalip Retard 400 mg, tabletten met gereguleerde afgifte

{
  "form": "Tablet met verlengde afgifte",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h18388_smpc.pdf",
  "strength": null,
  "atc_label": "Bezafibrate",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg132379",
  "excipients": [
    "COPOLYMEER VAN ETHYLACRYLAAT-METHYLMETHACRYLAAT (2:1) (E 1206)",
    "HYPROMELLOSE (Release controlling polymer)(E 464)",
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "LACTOSE 1-WATER",
    "MACROGOL 10000",
    "MAGNESIUMSTEARAAT (E 470b)",
    "NATRIUMLAURILSULFAAT",
    "POLYSORBAAT 80 (E 433)",
    "POVIDON K 25 (E 1201)",
    "SILICIUMDIOXIDE (E 551)",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)",
    "TRINATRIUMCITRAAT 2-WATER (E 331)"
  ],
  "substances": [
    "BEZAFIBRAAT"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h132379.pdf",
  "authorised_at": "2024/08/28",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "132379//18388",
  "additional_monitoring": "N"
}